SIGMAR1 and amyotrophic lateral sclerosis: In in vivo and in vitro models of ALS, BiP content predominantly increases in in vitro experiments and changes insignificantly in in vivo models along with the absence of Sigma1R expression amplification (Figure 1, Figure 2, Figure 3 and Figure 4).